SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3s2s'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OKC_A_SAMA500_1
(TYPE I RESTRICTION
ENZYME STYSJI M
PROTEIN)		 3s2s PUTATIVE
PYRAZINAMIDASE/NICOT
INAMIDASE
(Streptococcus
mutans) 		4 / 6 THR A 125
ASP A  46
ASN A  44
ASP A  43
 None
 1.27A 2okcA-3s2sA:
undetectable		 2okcA-3s2sA:
19.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2WT9_A_NIOA1216_1
(NICOTINAMIDASE)		 3s2s PUTATIVE
PYRAZINAMIDASE/NICOT
INAMIDASE
(Streptococcus
mutans) 		5 / 10 ASP A   9
ASP A  53
HIS A  55
TYR A 106
CYH A 136
 CAD  A 185 (-3.7A)
ZN  A 184 (-2.6A)
ZN  A 184 (-3.3A)
None
CAD  A 185 (-2.2A)
 1.12A 2wt9A-3s2sA:
22.2		 2wt9A-3s2sA:
32.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2WT9_A_NIOA1216_1
(NICOTINAMIDASE)		 3s2s PUTATIVE
PYRAZINAMIDASE/NICOT
INAMIDASE
(Streptococcus
mutans) 		7 / 10 ASP A   9
PHE A  14
LEU A  21
ASP A  53
HIS A  71
TYR A 106
CYH A 136
 CAD  A 185 (-3.7A)
CAD  A 185 (-3.3A)
None
ZN  A 184 (-2.6A)
ZN  A 184 (-3.4A)
None
CAD  A 185 (-2.2A)
 0.38A 2wt9A-3s2sA:
22.2		 2wt9A-3s2sA:
32.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2WT9_A_NIOA1216_1
(NICOTINAMIDASE)		 3s2s PUTATIVE
PYRAZINAMIDASE/NICOT
INAMIDASE
(Streptococcus
mutans) 		5 / 10 PHE A  14
LEU A  21
ASP A   9
TYR A 106
CYH A 136
 CAD  A 185 (-3.3A)
None
CAD  A 185 (-3.7A)
None
CAD  A 185 (-2.2A)
 1.30A 2wt9A-3s2sA:
22.2		 2wt9A-3s2sA:
32.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2WT9_B_NIOB1216_1
(NICOTINAMIDASE)		 3s2s PUTATIVE
PYRAZINAMIDASE/NICOT
INAMIDASE
(Streptococcus
mutans) 		6 / 9 ASP A   9
PHE A  14
LEU A  21
ASP A  53
HIS A  71
CYH A 136
 CAD  A 185 (-3.7A)
CAD  A 185 (-3.3A)
None
ZN  A 184 (-2.6A)
ZN  A 184 (-3.4A)
CAD  A 185 (-2.2A)
 0.34A 2wt9B-3s2sA:
22.1		 2wt9B-3s2sA:
32.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NNE_G_ACTG601_0
(CHOLINE OXIDASE)		 3s2s PUTATIVE
PYRAZINAMIDASE/NICOT
INAMIDASE
(Streptococcus
mutans) 		4 / 6 ALA A 141
ILE A 142
VAL A 176
HIS A 172
 None
 1.16A 3nneG-3s2sA:
undetectable		 3nneG-3s2sA:
15.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3O94_A_NCAA192_0
(NICOTINAMIDASE)		 3s2s PUTATIVE
PYRAZINAMIDASE/NICOT
INAMIDASE
(Streptococcus
mutans) 		5 / 11 ASP A   9
ASP A  53
GLU A  64
HIS A  55
TYR A 106
 CAD  A 185 (-3.7A)
ZN  A 184 (-2.6A)
ZN  A 184 (-2.5A)
ZN  A 184 (-3.3A)
None
 1.31A 3o94A-3s2sA:
35.9		 3o94A-3s2sA:
71.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3O94_A_NCAA192_0
(NICOTINAMIDASE)		 3s2s PUTATIVE
PYRAZINAMIDASE/NICOT
INAMIDASE
(Streptococcus
mutans) 		10 / 11 ASP A   9
PHE A  14
LEU A  21
ASP A  53
GLU A  64
PHE A  68
HIS A  71
TYR A 106
LEU A 132
ILE A 135
 CAD  A 185 (-3.7A)
CAD  A 185 (-3.3A)
None
ZN  A 184 (-2.6A)
ZN  A 184 (-2.5A)
None
ZN  A 184 (-3.4A)
None
CAD  A 185 (-3.9A)
CAD  A 185 (-3.4A)
 0.35A 3o94A-3s2sA:
35.9		 3o94A-3s2sA:
71.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3O94_B_NCAB192_0
(NICOTINAMIDASE)		 3s2s PUTATIVE
PYRAZINAMIDASE/NICOT
INAMIDASE
(Streptococcus
mutans) 		5 / 11 ASP A   9
ASP A  53
GLU A  64
HIS A  55
TYR A 106
 CAD  A 185 (-3.7A)
ZN  A 184 (-2.6A)
ZN  A 184 (-2.5A)
ZN  A 184 (-3.3A)
None
 1.30A 3o94B-3s2sA:
35.8		 3o94B-3s2sA:
71.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3O94_B_NCAB192_0
(NICOTINAMIDASE)		 3s2s PUTATIVE
PYRAZINAMIDASE/NICOT
INAMIDASE
(Streptococcus
mutans) 		10 / 11 ASP A   9
PHE A  14
LEU A  21
ASP A  53
GLU A  64
PHE A  68
HIS A  71
TYR A 106
LEU A 132
ILE A 135
 CAD  A 185 (-3.7A)
CAD  A 185 (-3.3A)
None
ZN  A 184 (-2.6A)
ZN  A 184 (-2.5A)
None
ZN  A 184 (-3.4A)
None
CAD  A 185 (-3.9A)
CAD  A 185 (-3.4A)
 0.29A 3o94B-3s2sA:
35.8		 3o94B-3s2sA:
71.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3O94_C_NCAC192_0
(NICOTINAMIDASE)		 3s2s PUTATIVE
PYRAZINAMIDASE/NICOT
INAMIDASE
(Streptococcus
mutans) 		5 / 11 ASP A   9
ASP A  53
GLU A  64
HIS A  55
TYR A 106
 CAD  A 185 (-3.7A)
ZN  A 184 (-2.6A)
ZN  A 184 (-2.5A)
ZN  A 184 (-3.3A)
None
 1.32A 3o94C-3s2sA:
35.7		 3o94C-3s2sA:
71.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3O94_C_NCAC192_0
(NICOTINAMIDASE)		 3s2s PUTATIVE
PYRAZINAMIDASE/NICOT
INAMIDASE
(Streptococcus
mutans) 		10 / 11 ASP A   9
PHE A  14
LEU A  21
ASP A  53
GLU A  64
PHE A  68
HIS A  71
TYR A 106
LEU A 132
ILE A 135
 CAD  A 185 (-3.7A)
CAD  A 185 (-3.3A)
None
ZN  A 184 (-2.6A)
ZN  A 184 (-2.5A)
None
ZN  A 184 (-3.4A)
None
CAD  A 185 (-3.9A)
CAD  A 185 (-3.4A)
 0.34A 3o94C-3s2sA:
35.7		 3o94C-3s2sA:
71.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3O94_D_NCAD192_0
(NICOTINAMIDASE)		 3s2s PUTATIVE
PYRAZINAMIDASE/NICOT
INAMIDASE
(Streptococcus
mutans) 		5 / 11 ASP A   9
ASP A  53
GLU A  64
HIS A  55
TYR A 106
 CAD  A 185 (-3.7A)
ZN  A 184 (-2.6A)
ZN  A 184 (-2.5A)
ZN  A 184 (-3.3A)
None
 1.31A 3o94D-3s2sA:
35.7		 3o94D-3s2sA:
71.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3O94_D_NCAD192_0
(NICOTINAMIDASE)		 3s2s PUTATIVE
PYRAZINAMIDASE/NICOT
INAMIDASE
(Streptococcus
mutans) 		10 / 11 ASP A   9
PHE A  14
LEU A  21
ASP A  53
GLU A  64
PHE A  68
HIS A  71
TYR A 106
LEU A 132
ILE A 135
 CAD  A 185 (-3.7A)
CAD  A 185 (-3.3A)
None
ZN  A 184 (-2.6A)
ZN  A 184 (-2.5A)
None
ZN  A 184 (-3.4A)
None
CAD  A 185 (-3.9A)
CAD  A 185 (-3.4A)
 0.34A 3o94D-3s2sA:
35.7		 3o94D-3s2sA:
71.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3R2J_A_NIOA311_1
(ALPHA/BETA-HYDROLASE
-LIKE PROTEIN)		 3s2s PUTATIVE
PYRAZINAMIDASE/NICOT
INAMIDASE
(Streptococcus
mutans) 		5 / 9 ASP A   9
LEU A  21
ASP A  53
HIS A  71
LYS A 103
 CAD  A 185 (-3.7A)
None
ZN  A 184 (-2.6A)
ZN  A 184 (-3.4A)
None
 0.49A 3r2jA-3s2sA:
23.0		 3r2jA-3s2sA:
28.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3R2J_B_NIOB311_1
(ALPHA/BETA-HYDROLASE
-LIKE PROTEIN)		 3s2s PUTATIVE
PYRAZINAMIDASE/NICOT
INAMIDASE
(Streptococcus
mutans) 		7 / 11 ASP A   9
PHE A  14
LEU A  21
ASP A  53
HIS A  71
LYS A 103
TYR A 106
 CAD  A 185 (-3.7A)
CAD  A 185 (-3.3A)
None
ZN  A 184 (-2.6A)
ZN  A 184 (-3.4A)
None
None
 0.51A 3r2jB-3s2sA:
22.6		 3r2jB-3s2sA:
28.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3R2J_C_NIOC311_1
(ALPHA/BETA-HYDROLASE
-LIKE PROTEIN)		 3s2s PUTATIVE
PYRAZINAMIDASE/NICOT
INAMIDASE
(Streptococcus
mutans) 		8 / 12 ASP A   9
PHE A  14
LEU A  21
ASP A  53
HIS A  55
HIS A  71
LYS A 103
TYR A 106
 CAD  A 185 (-3.7A)
CAD  A 185 (-3.3A)
None
ZN  A 184 (-2.6A)
ZN  A 184 (-3.3A)
ZN  A 184 (-3.4A)
None
None
 0.44A 3r2jC-3s2sA:
22.9		 3r2jC-3s2sA:
28.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3R2J_D_NIOD311_1
(ALPHA/BETA-HYDROLASE
-LIKE PROTEIN)		 3s2s PUTATIVE
PYRAZINAMIDASE/NICOT
INAMIDASE
(Streptococcus
mutans) 		7 / 11 ASP A   9
PHE A  14
LEU A  21
ASP A  53
HIS A  71
LYS A 103
TYR A 106
 CAD  A 185 (-3.7A)
CAD  A 185 (-3.3A)
None
ZN  A 184 (-2.6A)
ZN  A 184 (-3.4A)
None
None
 0.45A 3r2jD-3s2sA:
22.9		 3r2jD-3s2sA:
28.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3R9S_C_BEZC264_0
(CARNITINYL-COA
DEHYDRATASE)		 3s2s PUTATIVE
PYRAZINAMIDASE/NICOT
INAMIDASE
(Streptococcus
mutans) 		4 / 6 ALA A 141
ILE A 151
LEU A 128
ALA A 169
 None
 0.88A 3r9sC-3s2sA:
undetectable		 3r9sC-3s2sA:
23.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4G1B_D_ECND403_1
(FLAVOHEMOGLOBIN)		 3s2s PUTATIVE
PYRAZINAMIDASE/NICOT
INAMIDASE
(Streptococcus
mutans) 		5 / 12 ILE A  52
THR A  51
PHE A  50
VAL A 131
ILE A  30
 None
 1.10A 4g1bD-3s2sA:
6.7		 4g1bD-3s2sA:
18.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KRH_B_SAMB900_1
(PHOSPHOETHANOLAMINE
N-METHYLTRANSFERASE
2)		 3s2s PUTATIVE
PYRAZINAMIDASE/NICOT
INAMIDASE
(Streptococcus
mutans) 		4 / 4 ILE A   8
SER A   7
ASP A  53
ASP A  56
 None
None
ZN  A 184 (-2.6A)
None
 1.17A 4krhB-3s2sA:
undetectable		 4krhB-3s2sA:
19.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LVC_A_ADNA501_2
(S-ADENOSYL-L-HOMOCYS
TEINE HYDROLASE
(SAHASE))		 3s2s PUTATIVE
PYRAZINAMIDASE/NICOT
INAMIDASE
(Streptococcus
mutans) 		4 / 5 GLN A 150
THR A 125
THR A 140
LEU A 173
 None
 1.40A 4lvcA-3s2sA:
3.1		 4lvcA-3s2sA:
20.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LVC_C_ADNC501_2
(S-ADENOSYL-L-HOMOCYS
TEINE HYDROLASE
(SAHASE))		 3s2s PUTATIVE
PYRAZINAMIDASE/NICOT
INAMIDASE
(Streptococcus
mutans) 		4 / 5 GLN A 150
THR A 125
THR A 140
LEU A 173
 None
 1.39A 4lvcC-3s2sA:
3.5		 4lvcC-3s2sA:
20.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JGL_B_SAMB301_1
(UBIE/COQ5 FAMILY
METHYLTRANSFERASE,
PUTATIVE)		 3s2s PUTATIVE
PYRAZINAMIDASE/NICOT
INAMIDASE
(Streptococcus
mutans) 		3 / 3 ASP A 102
ASN A  72
PHE A  49
 None
 0.90A 5jglB-3s2sA:
2.2		 5jglB-3s2sA:
20.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JGL_B_SAMB301_1
(UBIE/COQ5 FAMILY
METHYLTRANSFERASE,
PUTATIVE)		 3s2s PUTATIVE
PYRAZINAMIDASE/NICOT
INAMIDASE
(Streptococcus
mutans) 		3 / 3 ASP A 102
ASN A  72
PHE A  99
 None
 0.86A 5jglB-3s2sA:
2.2		 5jglB-3s2sA:
20.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5M5K_A_ADNA502_2
(ADENOSYLHOMOCYSTEINA
SE)		 3s2s PUTATIVE
PYRAZINAMIDASE/NICOT
INAMIDASE
(Streptococcus
mutans) 		4 / 4 GLN A 150
THR A 125
THR A 140
LEU A 173
 None
 1.39A 5m5kA-3s2sA:
3.5		 5m5kA-3s2sA:
20.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5M5K_C_ADNC502_2
(ADENOSYLHOMOCYSTEINA
SE)		 3s2s PUTATIVE
PYRAZINAMIDASE/NICOT
INAMIDASE
(Streptococcus
mutans) 		4 / 4 GLN A 150
THR A 125
THR A 140
LEU A 173
 None
 1.40A 5m5kC-3s2sA:
3.1		 5m5kC-3s2sA:
20.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5M66_B_ADNB502_2
(ADENOSYLHOMOCYSTEINA
SE)		 3s2s PUTATIVE
PYRAZINAMIDASE/NICOT
INAMIDASE
(Streptococcus
mutans) 		4 / 4 GLN A 150
THR A 125
THR A 140
LEU A 173
 None
 1.39A 5m66B-3s2sA:
3.2		 5m66B-3s2sA:
20.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5NNW_D_GCSD302_1
(25 KDA PROTEIN
ELICITOR)		 3s2s PUTATIVE
PYRAZINAMIDASE/NICOT
INAMIDASE
(Streptococcus
mutans) 		4 / 7 ASP A  53
GLY A  54
HIS A  55
HIS A 105
 ZN  A 184 (-2.6A)
None
ZN  A 184 (-3.3A)
None
 1.07A 5nnwD-3s2sA:
undetectable		 5nnwD-3s2sA:
17.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5NO9_D_95ZD302_1
(25 KDA PROTEIN
ELICITOR)		 3s2s PUTATIVE
PYRAZINAMIDASE/NICOT
INAMIDASE
(Streptococcus
mutans) 		4 / 7 ASP A  53
GLY A  54
HIS A  55
HIS A 105
 ZN  A 184 (-2.6A)
None
ZN  A 184 (-3.3A)
None
 1.06A 5no9D-3s2sA:
undetectable		 5no9D-3s2sA:
17.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6F3M_B_ADNB502_2
(-)		 3s2s PUTATIVE
PYRAZINAMIDASE/NICOT
INAMIDASE
(Streptococcus
mutans) 		4 / 4 GLN A 150
THR A 125
THR A 140
LEU A 173
 None
 1.39A 6f3mB-3s2sA:
3.5		 6f3mB-3s2sA:
20.80